Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
63
Number of overlapping holdings
100.0%
% of XLV's 63 holdings also in FHLC
18.3%
% of FHLC's 369 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus FHLC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in FHLC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.2% | 10.2% | 10.2% |
|
UNITEDHEALTH GROUP INC | 9.4% | 8.3% | 8.3% |
|
JOHNSON & JOHNSON | 6.9% | 6.1% | 6.1% |
|
ABBVIE INC | 6.0% | 5.2% | 5.2% |
|
MERCK & CO. INC. | 5.2% | 5.0% | 5.0% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to FHLC
|
ELI LILLY & CO | 3.0% |
|
UNITEDHEALTH GROUP INC | 1.1% |
|
ABBVIE INC | 0.8% |
|
JOHNSON & JOHNSON | 0.8% |
|
INTUITIVE SURGICAL INC | 0.6% |
|
ABBOTT LABORATORIES | 0.5% |
|
THERMO FISHER SCIENTIFIC INC | 0.4% |
 |
MEDTRONIC PLC | 0.4% |
|
BOSTON SCIENTIFIC CORP | 0.3% |
|
REGENERON PHARMACEUTICALS | 0.3% |
XLV Underweight Relative to FHLC
|
ALNYLAM PHARMACEUTICALS INC | -0.5% |
|
VEEVA SYSTEMS INC-CLASS A | -0.5% |
|
ILLUMINA INC | -0.3% |
|
AVANTOR, INC. | -0.3% |
|
BIOMARIN PHARMACEUTICAL INC | -0.2% |
|
UNITED THERAPEUTICS CORP | -0.2% |
|
NEUROCRINE BIOSCIENCES INC | -0.2% |
|
TENET HEALTHCARE CORP | -0.2% |
|
NATERA INC | -0.2% |
|
SAREPTA THERAPEUTICS INC | -0.2% |